This poster presents a technology, based upon the reporter gene assay format, that allows assessment and quantification of the presence, activity, and function of a therapeutic AAV vector.
Using a proprietary developed reporter gene cell line – the iLite cGMP/GC - it showcases examples from the development, validation, and production of this custom genetically modified cell line and subsequent assay using it in an assay-ready format.